KR960000214A - 상처피부 치유용 분말제제 - Google Patents

상처피부 치유용 분말제제 Download PDF

Info

Publication number
KR960000214A
KR960000214A KR1019950015048A KR19950015048A KR960000214A KR 960000214 A KR960000214 A KR 960000214A KR 1019950015048 A KR1019950015048 A KR 1019950015048A KR 19950015048 A KR19950015048 A KR 19950015048A KR 960000214 A KR960000214 A KR 960000214A
Authority
KR
South Korea
Prior art keywords
powder
salts
healing
damaged skin
soluble polymer
Prior art date
Application number
KR1019950015048A
Other languages
English (en)
Other versions
KR100370313B1 (ko
Inventor
토시오 이나기
사이비 수에히로
Original Assignee
미와 타카야수
코와 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 미와 타카야수, 코와 가부시키가이샤 filed Critical 미와 타카야수
Publication of KR960000214A publication Critical patent/KR960000214A/ko
Application granted granted Critical
Publication of KR100370313B1 publication Critical patent/KR100370313B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)

Abstract

백당50~90중량%, 포비돈-요드 0.5~10중량%, 폴리비닐알코올, 폴리비닐 피롤리돈, 폴리아크릴산 및 그의 염, 풀루란, 카르복시빌닐 폴리머, 메틸셀루로오즈, 히드록시메틸셀루로오즈, 히드록시프로필메틸셀루로오즈 및 카르복시메틸셀루로오즈 및 그의 염에서 선택된 수용성 고분자 담체로 이루어진 손상피부 치유용 분말제를 개시한다. 이 분말제제는 운반시의 진동을 받아도, 또한 장기간 보존하여도 고결을 일으키지 않고, 사용시 비산하지 않고, 상처면에 부착성이 양호하다.

Description

상처피부 치유용 분말제제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. (a)백당 50~90중량%; (b)포비돈-요드 0.5~10 중량%; (c)폴리비닐알코올, 폴리비닐 리폴리돈, 폴리아크릴산 및 그의 염ㅇ, 풀루란, 카르복시비닐 폴리머, 메틸셀루로오즈, 히드록시메틸셀루로오즈, 히드록시프로필 메틸셀루로오즈 및 카르복시메틸셀루로오즈 및 그의 염에서 선택된 수용성 고분자 담체로 이루어진 손상피부 치유용 분말제.
  2. 제1항에 있어서, 수용성 고분자 담체(c)가 전조성물에 대해 1~40중량% 함유된 것이 특징인 손상피부 치유용 분말제.
  3. 제1항에 있어서, (d)당알코올이 추가된 것이 특징인 손상피부 치유용 분말제.
  4. 제3항에 있어서, 당알코올이 전조성물에 대해 10~30%의 양으로 함유된 것이 특징인 손상피부 치유용 분말제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019950015048A 1994-06-27 1995-06-08 상처피부치유용분말제제 KR100370313B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP144393/1994 1994-06-27
JP14439394A JP3583166B2 (ja) 1994-06-27 1994-06-27 損傷皮膚修復用粉末製剤

Publications (2)

Publication Number Publication Date
KR960000214A true KR960000214A (ko) 1996-01-25
KR100370313B1 KR100370313B1 (ko) 2003-03-19

Family

ID=15361113

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950015048A KR100370313B1 (ko) 1994-06-27 1995-06-08 상처피부치유용분말제제

Country Status (12)

Country Link
US (1) US5618799A (ko)
EP (1) EP0689841B1 (ko)
JP (1) JP3583166B2 (ko)
KR (1) KR100370313B1 (ko)
CN (1) CN1059088C (ko)
AT (1) ATE230270T1 (ko)
CA (1) CA2150888A1 (ko)
DE (1) DE69529249T2 (ko)
DK (1) DK0689841T3 (ko)
ES (1) ES2189811T3 (ko)
SI (1) SI0689841T1 (ko)
TW (1) TW336173B (ko)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU722246B2 (en) * 1995-06-07 2000-07-27 Johnson & Johnson Consumer Products, Inc. Stable complexes of crosslinked polyvinylpyrrolidone and iodine and method of making the same
US6562885B1 (en) 1998-03-19 2003-05-13 Battelle Memorial Institute Composition for deactivating chemically and biologically active agents and method of making the same
WO1999065538A1 (en) 1998-06-19 1999-12-23 Oxibio, Inc. Medical device having anti-infective and contraceptive properties
US6414223B1 (en) * 1998-08-03 2002-07-02 Cargill, Incorporated Plants, seeds and oils having an elevated total monounsaturated fatty acid content
DE60038100T2 (de) 1999-02-26 2009-02-12 Johnson & Johnson Consumer Companies, Inc. Bioadhäsive antibakterielle wundheilungszusammensetzungen
JP2001122790A (ja) * 1999-10-22 2001-05-08 Mikasa Seiyaku Co Ltd 安定な褥瘡・皮膚潰瘍および創傷治療用製剤
KR100978905B1 (ko) 2002-03-14 2010-08-31 가부시키가이샤 메드렉스 창상용 외용제
WO2004011032A1 (ja) * 2002-07-26 2004-02-05 Mikasa Seiyaku Co., Ltd. 外用剤
US20060034945A1 (en) * 2002-11-11 2006-02-16 Kowa Co., Ltd Composition for restoring damaged skin
US20040101507A1 (en) * 2002-11-27 2004-05-27 Janco Predovan Skin cream
AU2003293818A1 (en) * 2002-12-19 2004-07-14 Gunther Beisel Method for producing agents which are to be administered orally and corresponding compositions using polymers and coatings thereof consisting of hydrophilic liquids
RU2245723C1 (ru) * 2003-07-24 2005-02-10 Вилесов Александр Дмитриевич Средство и способ лечения гнойно-воспалительных заболеваний мягких тканей
WO2005027940A1 (ja) * 2003-09-22 2005-03-31 Kowa Co., Ltd. 損傷皮膚修復用貼付剤
US7673841B2 (en) 2004-03-25 2010-03-09 Cooper Technologies Company Hangar bar for recessed luminaires with integral nail
JP4575705B2 (ja) * 2004-04-23 2010-11-04 興和株式会社 損傷皮膚修復用組成物
JP4575706B2 (ja) * 2004-04-23 2010-11-04 興和株式会社 損傷皮膚修復用組成物
US7334538B1 (en) * 2004-07-27 2008-02-26 Aquascience Research Group, Inc. Topical medicants for aquatic animals
CN1279917C (zh) * 2004-09-09 2006-10-18 吕益明 一种创伤药及其制备方法和使用方法
WO2006118137A1 (ja) 2005-04-26 2006-11-09 Dainippon Sumitomo Pharma Co., Ltd. ビグアナイド系薬物を含有する粒状製剤
NZ542258A (en) * 2005-09-06 2010-05-28 Comvita New Zealand Ltd A medical composition comprising honey or sugar syrup and a viscosity increasing agent for use on wounds
US8664295B2 (en) * 2005-10-28 2014-03-04 Nutripol Capital Sarl Polymeric compound, method of preparing a polymeric compound, use of a polymeric compound
WO2008050847A1 (fr) 2006-10-25 2008-05-02 Dainippon Sumitomo Pharma Co., Ltd. Préparation granulaire non agglutinante
EP2100610A4 (en) 2006-12-07 2009-12-02 Daiichi Sankyo Co Ltd PHARMACEUTICAL COMPOSITION WITH LOW SUBSTITUTED HYDROXYPROPYL CELLULOSE
TWI428151B (zh) * 2006-12-07 2014-03-01 Daiichi Sankyo Co Ltd 含有甘露醇或乳糖之固形製劑
JPWO2008069262A1 (ja) * 2006-12-07 2010-03-25 第一三共株式会社 安定性が改善されたフィルムコーティング製剤
KR101647842B1 (ko) * 2006-12-07 2016-08-11 다이이찌 산쿄 가부시키가이샤 저장 안정성이 개선된 의약 조성물
EP2349358A4 (en) * 2008-09-22 2013-04-24 Triomed Innovations Corp NEW MANUFACTURING PROCESS FOR IODED RESIN AND PRODUCT
CN101654499B (zh) * 2009-09-02 2011-08-31 陈煜� 天然高分子或其水溶性衍生物的两亲性接枝共聚物与纳米碘复合物及其制备方法
CN102846776B (zh) * 2012-09-28 2015-02-11 刘艳 一种由桃树末制成的药剂
JP2018500312A (ja) * 2014-12-30 2018-01-11 スリーエム イノベイティブ プロパティズ カンパニー 消毒組成物
MX2017009450A (es) * 2015-01-20 2018-01-18 Veloce Biopharma Llc Composicion yodofora novedosa y metodos de uso.
EP4340848A1 (en) * 2021-05-18 2024-03-27 Povinez LLC Nasal antiseptic

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2353297A1 (fr) * 1976-01-26 1977-12-30 Tissier Gerard Nouveaux complexes neutres et insolubles de la polyvinylpolypyrrolidone et des halogenes, leurs procedes d'obtention et leurs applications
US4094967A (en) * 1976-10-22 1978-06-13 Allor Foundation Iodine-polyvinylpyrrolidone solid product and method of preparation
AU536885B2 (en) * 1979-04-18 1984-05-31 R. A. Knutson Wound and burn dressing
DE3312431A1 (de) * 1983-04-07 1984-10-11 B. Braun Melsungen Ag, 3508 Melsungen Pvp-iod-wundpuder mit synergistisch wirkender pudergrundlage
NL8500774A (nl) * 1985-03-18 1986-10-16 Dagra Nv Werkwijze ter bereiding van een vrij vloeiend, homogeen povidonjood wondpoeder.
CA1287584C (en) * 1986-09-02 1991-08-13 Seiichi Komori Wound-healing preparations
GB8622012D0 (en) * 1986-09-12 1986-10-22 Euro Celtique Sa Solid iodophor composition
CH678697A5 (ko) * 1989-04-03 1991-10-31 Warner Lambert Co
US4877927A (en) * 1989-04-06 1989-10-31 Hamlin Incorporated Extended dwell shock sensing device

Also Published As

Publication number Publication date
TW336173B (en) 1998-07-11
DK0689841T3 (da) 2003-02-24
US5618799A (en) 1997-04-08
CN1059088C (zh) 2000-12-06
CN1124143A (zh) 1996-06-12
JPH0812582A (ja) 1996-01-16
DE69529249T2 (de) 2003-08-07
CA2150888A1 (en) 1995-12-28
KR100370313B1 (ko) 2003-03-19
SI0689841T1 (en) 2003-04-30
DE69529249D1 (de) 2003-02-06
ATE230270T1 (de) 2003-01-15
EP0689841B1 (en) 2003-01-02
EP0689841A1 (en) 1996-01-03
JP3583166B2 (ja) 2004-10-27
ES2189811T3 (es) 2003-07-16

Similar Documents

Publication Publication Date Title
KR960000214A (ko) 상처피부 치유용 분말제제
JPS5436359A (en) Preparation of polyolefin film
CA2227901A1 (en) Improved cement admixture product
AU5835998A (en) The use of redisperisble polymer powders or polymer granules for coating pharmaceutical or agrochemical use forms
BR9809109A (pt) Composição aglutinante de tinta em pó
KR910000703A (ko) 테트라졸 자극성 아미노산 수용체의 길항물질
ATE306254T1 (de) Zubereitungen mit verbesserter kontrollierter freisetzung
TR200102120T2 (tr) 3-(2,4,6-trimetilfenil)-4-neopentilkarboniloksi-5, 5-tetrametilen-delta3-dihidrofuran-2-on'un beyaz sineği kontrol etmek için kullanımı.
ITMI931326A1 (it) Composizione farmaceutica liquida per uso orale contenente acido 2-(4-isobutilfenil) propionico
CA2210076A1 (en) Enrofloxacin injection or infusion solutions
RU94026252A (ru) Модифицированные эластомерные полипропилены, способ модификации эластомерных полипропиленов, композиция на основе полиолефинов и неолефиновых термопластов
NO954952L (no) Fremgangsmåte for fremstilling av en oral fast-stoff doseringsform som inneholder diklofenac
DK0925283T3 (da) Hidtil ukendte polymeriserbare acylimidazolidinonmonomerer
NO971551D0 (no) Substansfrigjörende materialer
CO4940371A1 (es) Producto cosmetico removedor de tapones queratotonicos de la piel
WO2001001975A3 (en) Hypoestoxides, derivatives and agonists thereof for use as antiparasitic agents
HUP0200095A2 (hu) Permetezhető kozmetikai készítmény és mátrix, amely ebben a dermálisan adagolható készítményben használható
AU2001262559A1 (en) Sustained release composition comprising an active agent in a plastic carrier and shaped articles made therefrom
FR2832721B1 (fr) Composition granulee a base de matiere amylacee et son utilisation dans les domaines non alimentaires et non pharmaceutiques
ATE275577T1 (de) Quinapril magnesium enthaltende, pharmazeutisch wirksame zusammensetzung
RU2002135455A (ru) Гептапептид последовательности met-glu-his-phe-pro-gly-pro с нейропротекторной активностью и фармацевтическая композиция на его основе
FR2742675B1 (fr) Agent dispersant a base de lignosulfonate et son utilisation dans des formulations phytosanitaires solides
CA2250844A1 (en) Anti-hiv composition comprising imidazole derivatives
TW249802B (ko)
EP0729950A4 (en) ANTI-HIV MEDICINAL PRODUCTS

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20051209

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee